Search Results 1031-1040 of 18669 for hepatitis

1. A Study of Elotuzumab, Daratumumab, Iberdomide, and Dexamethasone for Relapsed Multiple Myeloma - Mayo Clinic

   ... hepatitis B (defined by a positive test for hepatitis B surface antigen [HBsAg]) at registration or ≤3 months prior to registration. Note: Participants ...

2. Study to Evaluate the Safety, Tolerability, PDs, and Efficacy of CNP-104 in Subjects With Primary Biliary Cholangitis - Mayo Clinic

   Subjects with concomitant liver diseases including chronic viral hepatitis B or C, autoimmune hepatitis, PSC, alcoholic liver disease, Wilson's disease, ...

3. Mayo Clinic: Exhaustion Renders Immune Cells Less Effective in Cancer Treatment

   T cell exhaustion was discovered a few years ago in the context of chronic viral infections such as cytomegalovirus (CMV), hepatitis and HIV. Researchers ...

4. Etanercept-szzs (subcutaneous route) - Side effects & dosage - Mayo Clinic

   Alcoholic hepatitis, moderate to severe or; Blood or bone marrow problems (eg, aplastic anemia, low white blood cells), history of or; Congestive heart ...

5. Aminophylline (intravenous route) - Side effects & uses - Mayo Clinic

   Liver disease (e.g., cirrhosis, hepatitis) or; Pulmonary edema (lung condition) or; Shock (serious condition with very little blood flow in the body)—Use with ...

6. A Study of the Safety and Effectiveness of HBI-8000 with Nivolumab to Treat Melanoma, Renal Cell Carcinoma and Non-Small Cell Lung Cancer - Mayo Clinic

   Active hepatitis B (serum hepatitis B surface antigen [HBV sAg] positive), or hepatitis C (hepatitis C virus [HCV] antibody test or serum hepatitis C ...

7. A Study to Evaluate Chemoradiotherapy with or without Atezolizumab in Treating Patients With Localized Muscle Invasive Bladder Cancer - Mayo Clinic

   If patient has a known history of hepatitis B virus (HBV) or hepatitis C virus (HCV), they must meet the following criteria within 28 days prior to ...

8. Ph 1b Study to Evaluate GSK2110183 in Combination with Bortezomib and Dexamethasone in Subjects with Multiple Myeloma - Mayo Clinic

   Subjects with a positive test for Hepatitis C (HCV) antibody are excluded, regardless of viral load. If hepatitis C antibody is positive, confirmatory tests may ...

9. A Study of AO-176 as Monotherapy Combinated with Bortezomib and Dexamethasone in Adults with Relapsed or Refractory Multiple Myeloma - Mayo Clinic

   Current active liver disease from any cause, including hepatitis A (hepatitis A virus IgM positive), hepatitis B (hepatitis B virus [HBV] surface antigen ...

10. Secukinumab (intravenous route, subcutaneous route) - Side effects & dosage - Mayo Clinic

    Hepatitis B, history of or; Inflammatory bowel disease (eg, Crohn disease or ulcerative colitis)—Use with caution. May make these conditions worse. Infection ...